Patrono, Carlo

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal

Coronary Interventions and DiagnosticsAcute Myocardial Infarction Research

Cited by 7,166

Platelet Activation and Atherothrombosis

Davì, G., & Patrono, C. (2007) · New England Journal of Medicine

Platelet Disorders and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 2,135

In Vivo Formation of 8-Iso-Prostaglandin F2αand Platelet Activation in Diabetes Mellitus: Effects of Improved Metabolic Control and Vitamin E Supplementation

Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation

Antioxidant Activity and Oxidative StressEicosanoids and Hypertension Pharmacology

Cited by 742

Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus

Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., & Patrono, C. (1990) · New England Journal of Medicine

Platelet Disorders and TreatmentsEicosanoids and Hypertension Pharmacology

Cited by 597

Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease

Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology

Antioxidant Activity and Oxidative StressEicosanoids and Hypertension Pharmacology

Cited by 453

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

Scally, B., Emberson, J. R., Spata, E., Reith, C., Davies, K., Halls, H., Holland, L., Wilson, K., Bhala, N., Hawkey, C., et al. (2018) · The Lancet Gastroenterology & Hepatology

Helicobacter pylori-related gastroenterology studiesGastrointestinal Bleeding Diagnosis and Treatment

Cited by 259

Diabetes Mellitus, Hypercholesterolemia, and Hypertension but Not Vascular Disease Per Se Are Associated With Persistent Platelet Activation In Vivo: Evidence Derived From the Study of Peripheral Arterial Disease

Davı̀, G., Gresele, P., Violi, F., Basili, S., Catalano, M., Giammarresi, C., Volpato, R., Nenci, G. G., Ciabattoni, G., & Patrono, C. (1997) · Circulation

Platelet Disorders and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 223

In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes

Zaccardi, F., Rizzi, A., Petrucci, G., Ciaffardini, F., Tanese, L., Pagliaccia, F., Cavalca, V., Ciminello, A., Habib, A., Squellerio, I., et al. (2016) · Diabetes

Antiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and Treatments

Cited by 53